Prognosis after Implantation of Cardioverter-Defibrillators in Korean Patients with Brugada Syndrome

被引:10
|
作者
Son, Myoung Kyun [1 ]
Byeon, Kyeongmin [1 ]
Park, Seung-Jung [1 ]
Kim, June Soo [1 ]
Nam, Gi-Byoung [2 ]
Choi, Kee-Joon [2 ]
Kim, You-Ho [2 ]
Park, Sang Weon [3 ]
Kim, Young-Hoon [3 ]
Park, Hyung Wook [4 ]
Cho, Jeong Gwan [4 ]
On, Young Keun [1 ]
机构
[1] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Cardiac & Vasc Ctr,Dept Internal Med,Div Cardiol, Seoul 135710, South Korea
[2] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Internal Med,Div Cardiol, Seoul, South Korea
[3] Korea Univ, Coll Med, Ctr Cardiovasc, Dept Internal Med,Div Cardiol, Seoul 136705, South Korea
[4] Chonnam Natl Univ, Chonnam Natl Univ Hosp, Heart Res Ctr, Kwangju, South Korea
关键词
Brugada syndrome; implantable cardioverter-defibrillator; sudden death; syncope; Korea; LONG-TERM PROGNOSIS; RISK STRATIFICATION; INDIVIDUALS; ELECTROCARDIOGRAM; REGISTRY; SYNCOPE; ECG;
D O I
10.3349/ymj.2014.55.1.37
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose: Our study aims to analyze prognosis after implantable cardioverter-defibrillator (ICD) implantation in Korean patients with Brugada syndrome (BrS). Materials and Methods: This was a retrospective study of BrS patients implanted with an ICD at one of four centers in Korea between January 1998 and April 2012. Sixty-nine patients (68 males, 1 female) were implanted with an ICD based on aborted cardiac arrest (n=38, 55%), history of syncope (n=17, 25%), or induced ventricular tachyarrhythmia on electrophysiologic study in asymptomatic patients (n=14, 20%). A family history of sudden cardiac death and a spontaneous type 1 electrocardiography (ECG) were noted in 13 patients (19%) and 44 patients (64%), respectively. Results: During a mean follow-up of 59 +/- 46 months, 4.6 +/- 5.5 appropriate shocks were delivered in 19 patients (28%). Fourteen patients (20%) experienced 5.2 +/- 8.0 inappropriate shocks caused by supraventricular arrhythmia, lead failure, or abnormal sensing. Six patients were admitted for cardiac causes during follow-up, but no cardiac deaths occurred. An episode of aborted cardiac arrest was a significant predictor of appropriate shock, and the composite of cardiac events in the Cox proportional hazard model [hazard ratio (95% confidence interval) was 11.34 (1.31-97.94) and 4.78 (1.41-16.22), respectively]. However, a spontaneous type 1 ECG was not a predictor of cardiac events. Conclusion: Appropriate shock (28%) and inappropriate shock (20%) were noted during a mean follow-up of 59 +/- 46 months in Korean BrS patients implanted with an ICD. An episode of aborted cardiac arrest was the most powerful predictor of cardiac events.
引用
收藏
页码:37 / 45
页数:9
相关论文
共 50 条
  • [1] Prognosis Determinants after Cardioverter-Defibrillators Implantation in Brazil
    Migowski, Arn
    de Aquino Xavier, Regina Maria
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2017, 108 (03) : 283 - 283
  • [2] Prognosis Determinants after Cardioverter-Defibrillators Implantation in Brazil Reply
    da Silva, Katia Regina
    Albertini, Caio Marcos de Moraes
    Crevelari, Elizabeth Sartori
    de Carvalho, Eduardo Infante Januzzi
    Fiorelli, Alfredo Inacio
    Martinelli Filho, Martino
    Costa, Roberto
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2017, 108 (03) : 284 - 284
  • [3] Implantation of cardioverter-defibrillators
    Sellmann, T.
    Winterhalter, M.
    Herold, U.
    Kienbaum, P.
    ANAESTHESIST, 2010, 59 (06): : 507 - 518
  • [4] Implantable Cardioverter-Defibrillators in Children and Adolescents With Brugada Syndrome
    Corcia, M. Cecilia Gonzalez
    Sieira, Juan
    Pappaert, Gudrun
    de Asmundis, Carlo
    Chierchia, Gian Battista
    La Meir, Mark
    Sarkozy, Andrea
    Brugada, Pedro
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (02) : 148 - 157
  • [5] Cost-effectiveness of implantable cardioverter-defibrillators in Brugada syndrome treatment
    Wang, Kai
    Yamauchi, Kazunobu
    Li, Ping
    Kato, Hiroki
    Kobayashi, Makoto
    Kato, Ken
    Shimizu, Yoshiyuki
    JOURNAL OF MEDICAL SYSTEMS, 2008, 32 (01) : 51 - 57
  • [6] Cost-Effectiveness of Implantable Cardioverter-Defibrillators in Brugada Syndrome Treatment
    Kai Wang
    Kazunobu Yamauchi
    Ping Li
    Hiroki Kato
    Makoto Kobayashi
    Ken Kato
    Yoshiyuki Shimizu
    Journal of Medical Systems, 2008, 32 : 51 - 57
  • [7] IMPLANTATION OF NONTHOREACOTOMY CARDIOVERTER-DEFIBRILLATORS IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY
    PHILIPPON, F
    EPSTEIN, AE
    VOSHAGE, L
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1994, : A112 - A112
  • [8] Surface Electrocardiogram Screening for Subcutaneous Implantable Cardioverter-Defibrillators in Japanese Patients With and Without Brugada Syndrome
    Kawabata, Mihoko
    Goya, Masahiko
    Sasaki, Takeshi
    Maeda, Shingo
    Yagishita, Atsuhiko
    Shirai, Yasuhiro
    Kaneko, Masakazu
    Shiohira, Shinya
    Isobe, Mitsuaki
    Hirao, Kenzo
    CIRCULATION JOURNAL, 2017, 81 (07) : 981 - 987
  • [9] Patients With Brugada Syndrome and Implanted Cardioverter-Defibrillators Long-Term Follow-Up
    Hernandez-Ojeda, Jaime
    Arbelo, Elena
    Borras, Roger
    Berne, Paola
    Tolosana, Jose M.
    Gomez-Juanatey, Andrea
    Berruezo, Antonio
    Campuzano, Oscar
    Sarquella-Brugada, Georgia
    Mont, Lluis
    Brugada, Ramon
    Brugada, Josep
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 70 (16) : 1991 - 2002
  • [10] SHOULD IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS BE ACTIVATED IMMEDIATELY AFTER IMPLANTATION
    COHEN, TJ
    POGO, G
    GOLDNER, BG
    MARCHANT, D
    AMERICAN HEART JOURNAL, 1994, 127 (02) : 480 - 482